脑FDG PET对急性住院老年患者新发现临床不确定认知障碍短期至中期认知下降及需辅助生活预测的价值
本研究纳入96例急性住院新发现临床不确定认知障碍的老年患者,以脑FDG PET视觉判读分为神经退行性(DEG+)与非神经退行性(DEG-),并计算总低代谢体积(THV)。DEG+患者CDR-SB年变化更高且与THV正相关,DEG+患者更早从家中转入辅助生活;生存与DEG状态或THV无关联。作者认为脑FDG PET有助于预测1至2年内认知/功能下降及辅助生活需求。
要点
- DEG+患者CDR-SB年变化为2.78±2.44,高于DEG-患者的0.99±1.81(P=0.001)。
- CDR-SB年变化与THV呈正相关(年龄校正Spearman ρ=0.392,P=0.001)。
- DEG+患者较DEG-患者更早从家中转入辅助生活(P=0.050),生存与DEG状态或THV无关联。
核心结论
- 在急性住院新发现临床不确定认知障碍的老年患者中,脑FDG PET可有助于预测1至2年内进一步的认知/功能下降及辅助生活需求。
研究设计与样本
- 研究纳入96例急性住院新发现临床不确定认知障碍的老年患者(女性62例,年龄81.4±5.4岁;德国临床试验注册号DRKS00005041)。
- FDG PET由2名独立读片者视觉判读分为神经退行性(DEG+)或非神经退行性(DEG-),并以体素水平对健康对照检验(P<0.001未校正)得出总低代谢体积(THV)。
- 基线FDG PET findings与PET后12至24个月居住状况变化及生存状态变化进行关联分析;CDR-SB年变化在72例亚组中分析。
主要发现
- PET至随访平均时间在DEG+与DEG-患者间无显著差异(1.37±0.27年 vs 1.41±0.27年,P=0.539)。
- CDR-SB年变化DEG+患者为2.78±2.44,高于DEG-患者的0.99±1.81(P=0.001)。
- CDR-SB年变化与THV呈正相关(年龄校正Spearman ρ=0.392,P=0.001)。
- DEG+患者较DEG-患者更早从家中转入辅助生活(P=0.050)。
- 生存与DEG状态或THV无关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to evaluate brain FDG PET for short- to medium-term prediction of cognitive decline, need for assisted living, and survival in acutely hospitalized geriatric patients with newly detected clinically uncertain cognitive impairment (CUCI). MATERIALS AND METHODS: The study included 96 patients (62 females, 81.4 ± 5.4 years) hospitalized due to (sub)acute admission indications with newly detected CUCI (German Clinical Trials Register DRKS00005041). FDG PET was categorized as "neurodegenerative" (DEG+) or "nonneurodegenerative" (DEG-) based on visual inspection by 2 independent readers. In addition, each individual PET was tested voxel-wise against healthy controls (P < 0.001 uncorrected). The resulting total hypometabolic volume (THV) served as reader-independent measure of the spatial extent of neuronal dysfunction/degeneration. FDG PET findings at baseline were tested for association with the change in living situation and change in vital status 12 to 24 months after PET. The association with the annual change of the CDR-SB (Clinical Dementia Rating Sum of Boxes) after PET was tested in a subsample of 72 patients. RESULTS: The mean time between PET and follow-up did not differ between DEG+ and DEG- patients (1.37 ± 0.27 vs 1.41 ± 0.27 years, P = 0.539). Annual change of CDR-SB was higher in DEG+ compared with DEG- patients (2.78 ± 2.44 vs 0.99 ± 1.81, P = 0.001), and it was positively correlated with THV (age-corrected Spearman ρ = 0.392, P = 0.001). DEG+ patients moved from at home to assisted living significantly earlier than DEG- patients (P = 0.050). Survival was not associated with DEG status or with THV. CONCLUSIONS: In acutely hospitalized geriatric patients with newly detected CUCI, the brain FDG PET can contribute to the prediction of further cognitive/functional decline and the need for assisted living within 1 to 2 years.
引用
- Lange C, Mäurer A, Suppa P, et al. Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive Impairment. Clin Nucl Med. 2022. PMID: 35006106. doi:10.1097/RLU.0000000000003981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。